Literature DB >> 2881350

Arginine vasopressin as a thyrotropin-releasing hormone.

M D Lumpkin, W K Samson, S M McCann.   

Abstract

Although hypothyroidism (with concomitant increased levels of thyroid-stimulating hormone) has been associated with elevated plasma vasopressin, the role that vasopressin plays in controlling thyroid-stimulating hormone secretion from the adenohypophysis is not understood. In two in vitro pituitary cell systems, vasopressin caused a specific and dose-related release of thyroid-stimulating hormone from cells that was equal in potency to that elicited by thyrotropin-releasing hormone, the primary acknowledged regulator of thyroid-stimulating hormone release. When injected into the hypothalamus, however, vasopressin specifically inhibited the release of thyroid-stimulating hormone. Thus, vasopressin may exert differential regulatory effects on thyroid-stimulating hormone secretion in the hypothalamus and pituitary gland.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881350     DOI: 10.1126/science.2881350

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  7 in total

1.  Extrapituitary expression of the rat V1b vasopressin receptor gene.

Authors:  S J Lolait; A M O'Carroll; L C Mahan; C C Felder; D C Button; W S Young; E Mezey; M J Brownstein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

Review 2.  Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity.

Authors:  F Holsboer
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

3.  Cachectin alters anterior pituitary hormone release by a direct action in vitro.

Authors:  L Milenkovic; V Rettori; G D Snyder; B Beutler; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

4.  Effect of lysine vasopressin on basal and TRH stimulated TSH and PRL release in normal men.

Authors:  P Chiodera; A Gnudi; C Marchesi; G Rossi; L Camellini; A Caiazza; L Bianconi; R Volpi; V Coiro
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

5.  Regulation of vasopressin gene expression: changes in the level, but not the size, of vasopressin mRNA following endocrine manipulations.

Authors:  D A Carter; K Pardy; D Murphy
Journal:  Cell Mol Neurobiol       Date:  1993-02       Impact factor: 5.046

6.  Role of a pituitary-specific transcription factor (pit-1/GHF-1) or a closely related protein in cAMP regulation of human thyrotropin-beta subunit gene expression.

Authors:  H J Steinfelder; S Radovick; M A Mroczynski; P Hauser; J H McClaskey; B D Weintraub; F E Wondisford
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

7.  Exogenous thyrotropin improves renal function in euthyroid patients, while serum creatinine levels are increased in hypothyroidism.

Authors:  Flore Duranton; Anouchka Lacoste; Patrick Faurous; Emmanuel Deshayes; Jean Ribstein; Antoine Avignon; Georges Mourad; Àngel Argilés
Journal:  Clin Kidney J       Date:  2013-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.